Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01814826
Title Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

Therapies

MLN4924

Azacitidine

Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Stanford University Stanford California 94305-5826 United States Details
Hospital Corporation of America-HealthOne, LLC Denver Colorado 80218 United States Details
Mayo Clinic - Jacksonville, FL Jacksonville Florida 32224 United States Details
University of Miami School of Medicine Miami Florida 33136 United States Details
UNC-Chapel Hill School of Medicine Chapel Hill North Carolina 27599 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Methodist Hospital San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field